NCT07122544

Brief Summary

Title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Condition of Patients with Chronic Obstructive Pulmonary Disease Background and Rationale: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder that significantly reduces patients' quality of life and functional capacity. In the search for supportive therapeutic strategies, there is growing interest in unconventional therapeutic environments such as therapeutic salt chambers. The underground climate of the "Wieliczka" Salt Mine in Poland - characterized by humidity 60-75%, temperature 12.9-14.5°C, high air purity and ionization - has shown therapeutic potential. However, the clinical effects of pulmonary rehabilitation conducted in such an environment in COPD patients remain insufficiently documented. Study Objective: To evaluate the effect of pulmonary rehabilitation and climatic therapy conducted in underground salt chambers on the clinical condition of patients with stable COPD. Research Question: Does pulmonary rehabilitation conducted in a subterranean salt mine environment offer measurable clinical benefits compared to standard surface-based rehabilitation? Study Design and Methods: This is a randomized, controlled, four-arm interventional study including 80 adult patients with a confirmed diagnosis of COPD according to the GOLD 2025 criteria. Participants will be randomly assigned to one of four groups: Group A: Pulmonary rehabilitation in underground therapeutic salt chambers (physical training + microclimate exposure). Group B: Pulmonary rehabilitation in a surface-level gymnasium (physical training without microclimate exposure). Group C: Passive stay in underground salt chambers (microclimate exposure without physical training). Group D: Health education only (control group, surface level). The intervention program consists of 16 consecutive working days of 3-hour daily sessions. The content of the rehabilitation varies depending on the assigned group and includes general conditioning exercises, respiratory exercises, relaxation training, and health education. Outcome Measures and Assessment Tools: Clinical assessments will be conducted at three time points: prior to the intervention (T0), immediately after the intervention (T1), and at a 3-month follow-up (T2 - for Groups A and B only). The monitored variables include: Exercise Tolerance: Incremental Shuttle Walk Test (ISWT) Health-Related Quality of Life: St. George's Respiratory Questionnaire COPD Symptoms and Risk Indexes: COPD Assessment Test (CAT), BODE Index Muscle Strength: Deadlift test, hand dynamometer, 30-second Chair Stand Test Respiratory Muscle Strength: Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) Body Composition: Bioelectrical Impedance Analysis (BIA) Dyspnea Scales: Borg Scale, modified Medical Research Council (mMRC) scale Chest Mobility: Measuring tape assessment The study is designed to evaluate both the immediate and long-term effects of different pulmonary rehabilitation models on clinical outcomes in COPD patients, with a focus on whether the underground environment enhances rehabilitation efficacy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Sep 2025Jan 2028

First Submitted

Initial submission to the registry

July 30, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 14, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

November 26, 2025

Status Verified

July 1, 2025

Enrollment Period

1.3 years

First QC Date

July 30, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

speleotherapy

Outcome Measures

Primary Outcomes (2)

  • Change in exercise tolerance (ISWT distance)

    Incremental Shuttle Walk Test (ISWT) used to assess functional exercise tolerance in COPD patients. Measured as distance walked in meters. Evaluates change from baseline to post-intervention and at 3-month follow-up to assess immediate and sustained effects of rehabilitation.

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • Change in quality of life (SGRQ-C total score)

    St. George's Respiratory Questionnaire version COPD (SGRQ-C) measures disease-specific quality of life.

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

Secondary Outcomes (6)

  • Change in Respiratory Muscle Strength

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • Change in Chest Mobility

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • Change in COPD Symptoms Severity

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • Change in Dyspnea Severity

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • Change in Muscle Strength

    Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)

  • +1 more secondary outcomes

Other Outcomes (2)

  • BODE Index

    Baseline (Day 1 only)

  • Post-Bronchodilator Spirometry

    Baseline (Day 1 only)

Study Arms (4)

Pulmonary Rehabilitation in Salt Chambers

EXPERIMENTAL

Participants undergo a 16-day pulmonary rehabilitation program conducted in therapeutic salt chambers. The intervention includes general fitness, respiratory and relaxation exercises, health education. Conducted under supervision of a multidisciplinary team (physiotherapist, nurse, dietitian, physician). Sessions take place in the underground salt chambers of the "Wessel" complex (Salt Mine 'Wieliczka', Wieliczka, Poland).

Behavioral: Therapeutic stay in subterranean sanatorium chambers (microclimate therapy)Behavioral: Breathing exercisesBehavioral: General fitness exercisesBehavioral: Relaxation trainingBehavioral: Health education

Surface Rehabilitation

ACTIVE COMPARATOR

Participants undergo the same 16-day pulmonary rehabilitation program as in Arm 1, but conducted in standard surface conditions without exposure to salt chamber microclimate.

Behavioral: Breathing exercisesBehavioral: General fitness exercisesBehavioral: Relaxation trainingBehavioral: Health education

Passive Stay in Salt Chambers

EXPERIMENTAL

Participants attend daily 180-minutes passive sessions in therapeutic salt chambers for 16 days, without any physical exercise component.

Behavioral: Therapeutic stay in subterranean sanatorium chambers (microclimate therapy)Behavioral: Health education

Health education only

ACTIVE COMPARATOR

Participants receive printed materials and general health education related to COPD management. No supervised exercise or microclimatic exposure is included.

Behavioral: Health education

Interventions

Characteristics of the underground environment in the Wieliczka sanatorium chambers: Stable climatic conditions: relative humidity ranging from 60-75%, temperature between 12.9-14.5°C; High chemical and biological air purity; Mineral content in the air: 2.7-8.1 mg/m³, consisting mainly of chloride, sodium, potassium, calcium, and fluoride ions; Air ionization: 1,200-4,700 aeroions/cm³ of air. Elevated atmospheric pressure: increased by approximately 16-20 mmHg compared to surface conditions.

Passive Stay in Salt ChambersPulmonary Rehabilitation in Salt Chambers

30 minutes daily. Breathing exercises will include active respiratory exercises, drainage and effective coughing techniques, resistance training of the respiratory muscles, chest mobilization and relaxation exercises, breathing through pursed lips, as well as short and prolonged exhalation exercises.

Pulmonary Rehabilitation in Salt ChambersSurface Rehabilitation

30 minutes daily. General conditioning exercises will incorporate components aimed at improving overall aerobic capacity (e.g., walking-based activities, dance routines, step exercises), flexibility and coordination (e.g., stretching and balance exercises), and strength (e.g., exercises using resistance bands or dumbbells). The training will be conducted in interval, circuit, and free-form formats. Resistance levels will be individually adjusted to the patient's capacity.

Pulmonary Rehabilitation in Salt ChambersSurface Rehabilitation

30 minutes, once during the entire cycle. Relaxation training will include rest in a seated position, with dimmed lighting and calming music.

Pulmonary Rehabilitation in Salt ChambersSurface Rehabilitation

Educational materials in printed form for distribution covering the following topics: COPD - information about the disease; Breathing exercises and bronchial hygiene; Benefits of physical activity, including examples of exercises that can be performed at home.

Health education onlyPassive Stay in Salt ChambersPulmonary Rehabilitation in Salt ChambersSurface Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines.
  • FEV1 ≥ 30% of the predicted value.
  • FEV1/FVC \< 0.7 after bronchodilator administration in spirometry.
  • Negative bronchodilator reversibility test.
  • Voluntary written consent to participate in the study.

You may not qualify if:

  • COPD exacerbation.
  • Active cancer or a history of cancer within the past five years.
  • Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol.
  • Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area.
  • Severe valvular heart disease.
  • Implanted cardioverter-defibrillator.
  • Diagnosed arrhythmias posing a risk of loss of consciousness.
  • Acute coronary artery disease.
  • Epilepsy.
  • Uncontrolled arterial hypertension despite medication.
  • Primary or secondary immunodeficiencies.
  • Respiratory failure requiring chronic or intermittent oxygen therapy.
  • Infectious diseases with fever during the experiment or within two weeks before the study.
  • Claustrophobia.
  • Pregnancy.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AKF Kraków

Krakow, Małopolska, 30-009, Poland

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Breathing ExercisesRelaxation Therapy

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy ModalitiesBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2025

First Posted

August 14, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

November 26, 2025

Record last verified: 2025-07

Locations